K L Phipps, J A Allen, K A Barrett, C J Day, M N Doan
{"title":"Left atrial decompression in dogs with heart failure secondary to myxomatous mitral valve disease: a long-term outcome study.","authors":"K L Phipps, J A Allen, K A Barrett, C J Day, M N Doan","doi":"10.1016/j.jvc.2026.07.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction/objectives: </strong>Left-sided congestive heart failure (CHF) secondary to myxomatous mitral valve disease carries high morbidity and mortality in dogs. Left atrial decompression (LAD) has been employed in severely affected dogs refractory to medical therapy, but long-term outcomes have not been reported. The aim of this study was to evaluate survival time following LAD, the frequency of iatrogenic atrial septal defect closure, the frequency of right-sided CHF, and the frequency of cardiac-related hospitalizations.</p><p><strong>Animals, materials and methods: </strong>A total of 111 client-owned dogs with stage B2, C, or D mitral valve disease undergoing LAD. A retrospective cohort study of patients treated between October 2018 and September 2021 was conducted. The primary outcome was time to cardiac-related death or euthanasia. Secondary outcomes included time to right-sided CHF, iatrogenic atrial septal defect closure, and frequency of CHF-related hospitalization.</p><p><strong>Results: </strong>Iatrogenic atrial septal defect closure occurred in 22 dogs (20.2%), most commonly when septal puncture was performed caudal to the fossa ovalis. Forty-seven dogs (42.3%) developed right-sided CHF after LAD, with onset ranging from 1 to 873 days. Twenty-five dogs (22.5%) were hospitalized for cardiac disease after the procedure. Median survival time was 379 days (range, 1-1282) after the LAD procedure.</p><p><strong>Study limitations: </strong>Given the retrospective design and absence of a medically managed control group, prospective studies are warranted to further define the long-term benefits of LAD.</p><p><strong>Conclusions: </strong>Left atrial decompression provided satisfactory survival times in dogs with advanced mitral valve disease refractory to standard therapy. Left CHF recurrence requiring hospitalization was uncommon, but right-sided CHF developed frequently, albeit with variable onset. Atrial septal defect closure was rare and may be minimized by puncturing within the fossa ovalis.</p>","PeriodicalId":48788,"journal":{"name":"Journal of Veterinary Cardiology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2026-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Veterinary Cardiology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1016/j.jvc.2026.07.003","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction/objectives: Left-sided congestive heart failure (CHF) secondary to myxomatous mitral valve disease carries high morbidity and mortality in dogs. Left atrial decompression (LAD) has been employed in severely affected dogs refractory to medical therapy, but long-term outcomes have not been reported. The aim of this study was to evaluate survival time following LAD, the frequency of iatrogenic atrial septal defect closure, the frequency of right-sided CHF, and the frequency of cardiac-related hospitalizations.
Animals, materials and methods: A total of 111 client-owned dogs with stage B2, C, or D mitral valve disease undergoing LAD. A retrospective cohort study of patients treated between October 2018 and September 2021 was conducted. The primary outcome was time to cardiac-related death or euthanasia. Secondary outcomes included time to right-sided CHF, iatrogenic atrial septal defect closure, and frequency of CHF-related hospitalization.
Results: Iatrogenic atrial septal defect closure occurred in 22 dogs (20.2%), most commonly when septal puncture was performed caudal to the fossa ovalis. Forty-seven dogs (42.3%) developed right-sided CHF after LAD, with onset ranging from 1 to 873 days. Twenty-five dogs (22.5%) were hospitalized for cardiac disease after the procedure. Median survival time was 379 days (range, 1-1282) after the LAD procedure.
Study limitations: Given the retrospective design and absence of a medically managed control group, prospective studies are warranted to further define the long-term benefits of LAD.
Conclusions: Left atrial decompression provided satisfactory survival times in dogs with advanced mitral valve disease refractory to standard therapy. Left CHF recurrence requiring hospitalization was uncommon, but right-sided CHF developed frequently, albeit with variable onset. Atrial septal defect closure was rare and may be minimized by puncturing within the fossa ovalis.
期刊介绍：
The mission of the Journal of Veterinary Cardiology is to publish peer-reviewed reports of the highest quality that promote greater understanding of cardiovascular disease, and enhance the health and well being of animals and humans. The Journal of Veterinary Cardiology publishes original contributions involving research and clinical practice that include prospective and retrospective studies, clinical trials, epidemiology, observational studies, and advances in applied and basic research.
The Journal invites submission of original manuscripts. Specific content areas of interest include heart failure, arrhythmias, congenital heart disease, cardiovascular medicine, surgery, hypertension, health outcomes research, diagnostic imaging, interventional techniques, genetics, molecular cardiology, and cardiovascular pathology, pharmacology, and toxicology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
